ArticleHaematologica2026

Real-world effectiveness and safety of belantamab mafodotin monotherapy in patients with relapsed/ refractory multiple myeloma treated in Europe.

Michele Cavo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.